LGALS3 and congestive heart failure: The evidence that galectin-3 plays a role in the pathogenesis of cirrhotic cardiomyopathy is as follows: (1) galectin-3 levels are significantly increased in the circulation of patients with chronic heart failure, independent of etiology [17].